This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by García de la Torre, N. Articles by Charro, A. L. Search for Related Content PubMed PubMed Citation Articles by García de la Torre, N. Articles by Charro, A. L. Related Collections Diabetes and Insulin Metabolism Obesity

Effects of Weight Loss after Bariatric Surgery for Morbid Obesity on Vascular Endothelial Growth Factor-A, Adipocytokines, and Insulin

Departments of Endocrinology and Nutrition (Metabolic Studies Foundation) (N.G.d.l.T., M.A.R., E.B., L.C., M.P., A.L.C.) and Surgery (E.A., C.H., A.S.-P., L.D.-V., A.J.T.), Hospital Clínico Universitario San Carlos, 28040 Madrid, Spain

Address all correspondence and requests for reprints to: Nuria García de la Torre, Department of Endocrinology and Nutrition, Hospital Clínico Universitario San Carlos, Martín Lagos s/n, 28040 Madrid, Spain. E-mail: nurialobo{at}hotmail.com.

Background: Adipocytes regulate blood vessel formation, and in turn endothelial cells promote preadipocyte differentiation through the expression of proangiogenic factors, such as vascular endothelial growth factor (VEGF)-A. Some adipocytokines and hormones also have an effect on vascular development.

Objectives: Our objectives were to analyze the relationship between weight and circulating VEGF-A in morbidly obese subjects before and after bariatric surgery, and investigate the relationship between circulating VEGF-A and certain adipocytokines and hormones regulating adipocytes.

Methods: A total of 45 morbidly obese women and nine lean females were included in the study. Patients underwent bariatric surgery: vertical banded gastroplasty (n = 17), gastric bypass (n = 17), and biliopancreatic diversion (n = 11). Serum samples for VEGF-A, adiponectin, leptin, ghrelin, and insulin were obtained preoperatively and 9–12 months after surgery.

Results: Obese patients showed significantly higher VEGF-A levels than controls (306.3 ± 170.3 vs. 187.6 ± 91.9 pg/ml; P = 0.04), decreasing to 246.1 ± 160.4 after surgery (P < 0.001), with no differences among surgical procedures. In controls there was an inverse correlation between VEGF-A and ghrelin (r = –0.85; P <.01), but not in obese patients. Leptin and insulin concentrations were increased in obese patients, with a significant decrease shown after weight loss with surgery. Conversely, adiponectin concentrations were lower in obese patients, with a significant increase shown after weight loss with surgery. Ghrelin was higher in controls than obese patients, decreasing after gastric bypass and biliopancreatic diversion, but not after vertical banded gastroplasty.

Conclusion: Serum VEGF-A levels are significantly higher in obese patients than in lean controls, decreasing after weight loss with bariatric surgery, behaving similarly to other hormones related to adipose mass like leptin and insulin.

This article has been cited by other articles:

				J. A Parnell and R. A Reimer Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1751 - 1759. [Abstract] [Full Text] [PDF]